TIAA Trust, National Association’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,186
Closed -$561K 413
2025
Q4
$561K Sell
3,186
-516
-14% -$84.3K ﹤0.01% 469
2025
Q3
$519K Sell
3,702
-741
-17% -$100K ﹤0.01% 479
2025
Q2
$558K Buy
4,443
+100
+2% +$12.5K ﹤0.01% 447
2025
Q1
$594K Buy
4,343
+768
+21% +$110K ﹤0.01% 427
2024
Q4
$547K Buy
3,575
+108
+3% +$18.2K ﹤0.01% 441
2024
Q3
$672K Sell
3,467
-563
-14% -$118K ﹤0.01% 415
2024
Q2
$934K Buy
4,030
+159
+4% +$34.6K ﹤0.01% 360
2024
Q1
$835K Buy
3,871
+369
+11% +$86.4K ﹤0.01% 374
2023
Q4
$906K Sell
3,502
-92
-3% -$22.6K ﹤0.01% 344
2023
Q3
$924K Buy
+3,594
New +$961K ﹤0.01% 334

Other funds holding BIIB

TIAA Trust, National Association's BIIB Position: Q1 2026 in Review

TIAA Trust, National Association sold out of Biogen (BIIB) in Q1 2026, closing a stake of 3,186 shares — an estimated $561K sold.

TIAA Trust, National Association first reported a position in BIIB in Q3 2023 and held it in 10 quarters. The position peaked at $934K in Q2 2024. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • TIAA Trust, National Association reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • TIAA Trust, National Association sold 3,186 Biogen shares in Q1 2026, an estimated $561K.
  • TIAA Trust, National Association first reported a position in Biogen in Q3 2023 and held it in 10 quarters.
  • TIAA Trust, National Association's Biogen position peaked at $934K in Q2 2024.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on TIAA Trust, National Association's 13F filing for Q1 2026, filed 12 May 2026.